Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q37821595)
Watch
English
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer.
scientific article published on 14 December 2010
In more languages
default values for all languages
No label defined
No description defined
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
review article
1 reference
stated in
Europe PubMed Central
title
The ribonucleotide reductase large subunit (RRM1) as a predictive factor in patients with cancer
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
main subject
patient
0 references
author
Lars Jordheim
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
Olivier Trédan
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
Charles Dumontet
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
Pascal Sève
series ordinal
2
object named as
Pascal Sève
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
publication date
14 December 2010
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
published in
Lancet Oncology Commission
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
volume
12
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
issue
7
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
page(s)
693-702
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
cites work
Ribonucleotide reductases
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The R1 component of mammalian ribonucleotide reductase has malignancy-suppressing activity as demonstrated by gene transfer experiments
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RRM1-induced metastasis suppression through PTEN-regulated pathways
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Suppression of lung tumor formation by the regulatory subunit of ribonucleotide reductase.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Broad overexpression of ribonucleotide reductase genes in mice specifically induces lung neoplasms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of transfected human ribonucleotide reductase M2 subunit in human cancer cells enhances their invasive potential
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overexpression of RRM2 decreases thrombspondin-1 and increases VEGF production in human cancer cells in vitro and in vivo: implication of RRM2 in angiogenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lung cancer and the human gene for ribonucleotide reductase subunit M1 (RRM1).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcript map and complete genomic sequence for the 310 kb region of minimal allele loss on chromosome segment 11p15.5 in non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Mechanism for ribonucleotide reductase inactivation by the anticancer drug gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Increased expression of the large subunit of ribonucleotide reductase is involved in resistance to gemcitabine in human mammary adenocarcinoma cells.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression microarray analysis and oligo array comparative genomic hybridization of acquired gemcitabine resistance in mouse colon reveals selection for chromosomal aberrations
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In vivo induction of resistance to gemcitabine results in increased expression of ribonucleotide reductase subunit M1 as the major determinant
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The determinants of sensitivity and acquired resistance to gemcitabine differ in non-small cell lung cancer: a role of ABCC5 in gemcitabine sensitivity
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Involvement of ribonucleotide reductase M1 subunit overexpression in gemcitabine resistance of human pancreatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine chemoresistance and molecular markers associated with gemcitabine transport and metabolism in human pancreatic cancer cells
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Possible antitumor activity of 1-(3-C-ethynyl-beta-D-ribo-pentofuranosyl)cytosine (ECyd, TAS-106) against an established gemcitabine (dFdCyd)-resistant human pancreatic cancer cell line
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RRM1 modulated in vitro and in vivo efficacy of gemcitabine and platinum in non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The potency of siRNA-mediated growth inhibition following silencing of essential genes is dependent on siRNA design and varies with target sequence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Predicting gemcitabine transport and toxicity in human pancreatic cancer cell lines with the positron emission tomography tracer 3'-deoxy-3'-fluorothymidine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell lines
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of gemcitabine- and cisplatin-related genes in non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
First-line systemic chemotherapy in the treatment of advanced non-small cell lung cancer: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gene expression as a predictive marker of outcome in stage IIB-IIIA-IIIB non-small cell lung cancer after induction gemcitabine-based chemotherapy followed by resectional surgery
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical efficacy and predictive molecular markers of neoadjuvant gemcitabine and pemetrexed in resectable non-small cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reductase subunits M1 and M2 mRNA expression levels and clinical outcome of lung adenocarcinoma patients treated with docetaxel/gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor BRCA1, RRM1 and RRM2 mRNA expression levels and clinical response to first-line gemcitabine plus docetaxel in non-small-cell lung cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
XPG mRNA expression levels modulate prognosis in resected non-small-cell lung cancer in conjunction with BRCA1 and ERCC1 expression.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
DNA synthesis and repair genes RRM1 and ERCC1 in lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized phase III trial of gemcitabine-based chemotherapy with in situ RRM1 and ERCC1 protein levels for response prediction in non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Positive expression of ERCC1 predicts a poorer platinum-based treatment outcome in Chinese patients with advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The immunohistochemical overexpression of ribonucleotide reductase regulatory subunit M1 (RRM1) protein is a predictor of shorter survival to gemcitabine-based chemotherapy in advanced non-small cell lung cancer (NSCLC)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polymorphisms in DNA repair genes modulate survival in cisplatin/gemcitabine-treated non-small-cell lung cancer patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of gemcitabine in patients with non-small cell lung cancer according to promoter polymorphisms of the ribonucleotide reductase M1 gene
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RRM1 single nucleotide polymorphism -37C-->A correlates with progression-free survival in NSCLC patients after gemcitabine-based chemotherapy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Polymorphisms of the ribonucleotide reductase M1 gene and sensitivity to platin-based chemotherapy in non-small cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
RRM1 and PTEN as prognostic parameters for overall and disease-free survival in patients with non-small-cell lung cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Feasibility and efficacy of molecular analysis-directed individualized therapy in advanced non-small-cell lung cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reduction is a cytosolic process in mammalian cells independently of DNA damage
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Significance of RRM1 and ERCC1 expression in resectable pancreatic adenocarcinoma
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
In situ protein expression of RRM1, ERCC1, and BRCA1 in metastatic breast cancer patients treated with gemcitabine-based chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reductase subunit M1 expression in resectable, muscle-invasive urothelial cancer correlates with survival in younger patients
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Expression of nucleoside transporters, deoxycitidine kinase, ribonucleotide reductase regulatory subunits, and gemcitabine catabolic enzymes in primary ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Ribonucleotide reductase M1 (RRM1) 2464G>A polymorphism shows an association with gemcitabine chemosensitivity in cancer cell lines.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An association between RRM1 haplotype and gemcitabine-induced neutropenia in breast cancer patients.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Evidence of RNAi in humans from systemically administered siRNA via targeted nanoparticles
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase I pharmacodynamic study of time and sequence dependency of hydroxyurea in combination with gemcitabine: a California Cancer Consortium Trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase II trial of triapine (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A Phase II study of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) and gemcitabine in advanced pancreatic carcinoma. A trial of the Princess Margaret hospital Phase II consortium
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synthesis, crystallization, and biological evaluation of an orally active prodrug of gemcitabine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Squalenoyl nanomedicine of gemcitabine is more potent after oral administration in leukemia-bearing rats: study of mechanisms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Synthesis and biological activity of a gemcitabine phosphoramidate prodrug
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Is class III beta-tubulin a predictive factor in patients receiving tubulin-binding agents?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identification of microRNA-21 as a biomarker for chemoresistance and clinical outcome following adjuvant therapy in resectable pancreatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Cytidine deaminase residual activity in serum is a predictive marker of early severe toxicities in adults after gemcitabine-based chemotherapies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1470-2045%2810%2970244-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1470-2045(10)70244-8
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
PubMed publication ID
21163702
1 reference
stated in
Europe PubMed Central
PubMed publication ID
21163702
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21163702%20AND%20SRC:MED&resulttype=core&format=json
retrieved
18 January 2020
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit